Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.

Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study record page revision tag was updated to v3.6.3, indicating a newer release of the page.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedNew help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment'. The page now shows a recruitment status note ('No longer looking for participants') and updates the site revision to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.5%

- Check30 days agoChange DetectedThe page displays Revision: v3.5.5, replacing the previous v3.5.4, indicating an updated version of the page content.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now displays Revision: v3.5.4, signaling a minor update to the page's release or documentation and not altering substantive information presented to users.SummaryDifference0.1%

- Check73 days agoChange DetectedClinicalTrials.gov’s page revision/version updated from **v3.5.2** to **v3.5.3**, indicating a site release rather than a change to the study information.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.